Search research articles
Contact Us
Filters
Showing results (41-50 of 165) with videos related to
Page
of 17
Sort By:
Bulletin Du Cancer
|
September 19, 2006
[The réseau de recherche sur le cancer: favoring a multi-disciplinary approach]
Anne-Marie Mes-Masson, Louise Champoux, Josée Hébert, et al.
Clinical Breast Cancer
|
May 13, 2009
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer
Maria Theodoulou, Gerald Batist, Susana Campos, et al.
Human Vaccines & Immunotherapeutics
|
May 2, 2015
Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study
Tahar Aboulkassim, Amber Yasmeen, Nizar Akil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy
Victor Cohen, Valerie Panet-Raymond, Nelly Sabbaghian, et al.
Frontiers in Pharmacology
|
March 14, 2013
Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisited
Lee Black, Gerald Batist, Denise Avard, et al.
Oncogene
|
May 4, 2004
Connexin43 pseudogene is expressed in tumor cells and inhibits growth
Mustapha Kandouz, Andrew Bier, George D Carystinos, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target
Andrew Bier, Irene Oviedo-Landaverde, Jing Zhao, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2022
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules
Alan Kaplan, David J Stewart, Gerald Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2024
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies
David J Stewart, Tim Ramsay, Vishal Navani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2013
Use of statins and the risk of death in patients with prostate cancer
Oriana Yu, Maria Eberg, Serge Benayoun, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 165) with videos related to
Sort By:
Page
of 17
Bulletin Du Cancer
|
September 19, 2006
[The réseau de recherche sur le cancer: favoring a multi-disciplinary approach]
Anne-Marie Mes-Masson, Louise Champoux, Josée Hébert, et al.
Clinical Breast Cancer
|
May 13, 2009
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer
Maria Theodoulou, Gerald Batist, Susana Campos, et al.
Human Vaccines & Immunotherapeutics
|
May 2, 2015
Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study
Tahar Aboulkassim, Amber Yasmeen, Nizar Akil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy
Victor Cohen, Valerie Panet-Raymond, Nelly Sabbaghian, et al.
Frontiers in Pharmacology
|
March 14, 2013
Physician recruitment of patients to non-therapeutic oncology clinical trials: ethics revisited
Lee Black, Gerald Batist, Denise Avard, et al.
Oncogene
|
May 4, 2004
Connexin43 pseudogene is expressed in tumor cells and inhibits growth
Mustapha Kandouz, Andrew Bier, George D Carystinos, et al.
Molecular Cancer Therapeutics
|
April 18, 2009
Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target
Andrew Bier, Irene Oviedo-Landaverde, Jing Zhao, et al.
Current Oncology (Toronto, Ont.)
|
April 21, 2022
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules
Alan Kaplan, David J Stewart, Gerald Batist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2024
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies
David J Stewart, Tim Ramsay, Vishal Navani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2013
Use of statins and the risk of death in patients with prostate cancer
Oriana Yu, Maria Eberg, Serge Benayoun, et al.
Page
of 17